Skip to content
The Definitive Source for MedTech Performance Data

Built for investors and grounded in the latest healthcare data, Qsight Alpha consistently outperforms consensus. It offers unparalleled visibility and precise insights into the sales performance of companies in the MedTech sector through monthly and quarterly tracking of manufacturers.

Guidepoint Qsight Alpha is a powerful tool designed specifically for institutional investors, using the largest datasets available to provide near real-time insights into manufacturer and product-level performance.

Harness the power of real-time data insights.

Qsight Alpha

With Qsight Alpha, investors can confidently navigate the complexities of the MedTech market, leveraging robust data to identify trends and opportunities ahead of the competition. By staying informed and proactive, investors using Qsight Alpha can capitalize on emerging market trends and position themselves strategically for success.

To use Qsight Alpha, simply access the platform to track monthly and quarterly sales data. This allows you to see beyond standard market consensus with greater accuracy. As an indispensable tool for investors, Qsight Alpha provides precise and predictive revenue visibility to make smarter, data-driven investment decisions in these rapidly evolving industries.

Comprehensive Coverage

Access data intelligence derived from an extensive dataset that includes purchasing data from over 3,500 healthcare facilities in the MedTech sector, point-of-sale data capturing medical aesthetics practices’ products and treatments from over 3,500 aesthetics locations, and more than 5,000 U.S. Durable Medical Equipment (DME) pharmacy locations.

Accurate Projections

Leveraging transactional data from over 3,500 healthcare facilities, this platform offers investors precise and predictive revenue visibility. Since 2021, the mean absolute percentage error in Qsight’s projections has been 1.68%. During this time, Qsight has been directionally accurate on 91.4% of sales projections when compared to Wall Street consensus estimates.

Real-Time Updates & Historical Data Access

Qsight Alpha updates weekly and offers detailed monthly data going back as far as 2010, aiding in comprehensive trend analysis and market understanding.

Advanced Tools & Expert Support

The platform includes performance monitoring tools and offers access to expert analysis for in-depth, industry-specific analytics.

Alpha

How Qsight Alpha Can Maximize Investment Potential

Market Visibility

Real-Time Sales Performance

Product & Category Performance Tracking

Competitive Analysis

Comprehensive MedTech Alpha Tool

Alpha Med Device

Retrieve sales forecasts for over 30 publicly listed MedTech companies in the United States. These forecasts are derived from purchasing information collected from 3,500 U.S. healthcare facilities.

Alpha Quant

Access data on spending across 120+ medical device tickers, formatted with monthly transactional granularity and updated weekly based on purchasing data from 3,500 U.S. healthcare facilities. This comprehensive dataset captures over $60 billion in total transactions annually, providing unparalleled insights into the MedTech market.

Alpha DME

Access product-level, pharmacy-level purchase order data capturing over $2.3 billion per year in medical equipment, devices, and supplies. This data is sourced from over 5,000 U.S. Durable Medical Equipment (DME) pharmacy locations.

Alpha Aesthetics

Access manufacturer product-level point-of-sale data capturing medical aesthetics practices’ products and treatments from over 3,500 U.S. aesthetics locations.

Frequently Asked Questions
About Qsight Alpha

Qsight Alpha provides detailed insights and data tracking for companies in the Aesthetics, MedTech and DME sectors.

Qsight Alpha stands out due to its ability to consistently outperform consensus forecasts and its access to comprehensive sales data from over 3,500 U.S. healthcare facilities. It provides unparalleled visibility into the anticipated revenues and performance of MedTech and Aesthetics companies.

Access manufacturer product-level point-of-sale data, capturing medical aesthetics practices’ products and treatments from over 3,500 U.S. aesthetics locations. Additionally, access pharmacy-level purchase order data, reflecting over $2.3 billion annually in medical equipment, devices, and supplies, alongside data sourced from more than 5,000 U.S. Durable Medical Equipment (DME) pharmacy locations

Qsight Alpha uses comprehensive data intelligence derived from an extensive dataset, including purchasing data from over 3,500 healthcare facilities.

This platform offers near real-time insights into manufacturer and product-level performance with a mean absolute percentage error of just 1.68% in its projections since 2021. With weekly updates and detailed monthly data going back to 2010, Qsight Alpha provides investors with precise and predictive revenue visibility.

Delivering More Than Just Data

Request a Demo Today

At Guidepoint Qsight, we empower decisions through unmatched, data-driven insights for the Aesthetics and MedTech industries. Send us your contact information today, and we’ll be in touch to discuss your concerns and overall needs. When it comes to data analytics, we’re the experts you can count on.

Industry Segment*
November 8, 2022

TAVR: A Turbulent Journey Through Pandemic Recovery

With the leader of the TAVR market, Edwards Lifesciences, reporting a small miss in their third quarter earnings report, Guidepoint Qsight analyzed the short term and long-term effects of COVID-19 on the overall U.S. TAVR market.

Request a Demo